1. Home
  2. ANEB vs FRSX Comparison

ANEB vs FRSX Comparison

Compare ANEB & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

N/A

Current Price

$2.43

Market Cap

96.8M

Sector

Health Care

ML Signal

N/A

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$2.19

Market Cap

7.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANEB
FRSX
Founded
2020
N/A
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
96.8M
7.7M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
ANEB
FRSX
Price
$2.43
$2.19
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.2K
15.9K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$452,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$1.98
52 Week High
$3.42
$18.41

Technical Indicators

Market Signals
Indicator
ANEB
FRSX
Relative Strength Index (RSI) 43.83 51.03
Support Level $2.33 $1.99
Resistance Level $2.49 $2.26
Average True Range (ATR) 0.09 0.10
MACD 0.00 -0.00
Stochastic Oscillator 46.43 55.27

Price Performance

Historical Comparison
ANEB
FRSX

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: